HIV, Trump and South Africa

Trump's aid cuts stop South African HIV vaccine trials in their tracks
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work. The first round of vaccines she and her colleagues made in Johannesburg had produced an immune response in rabbits,
HIV Vaccine Trials Halted Due to Trump Administration Cuts
Scientists believe they are on the cusp of a vaccine for HIV. Two promising vaccines were set to go to additional trials. But the vials of vaccines are in the freezer due to financial cuts by the Trump administration.
USAID Funding Freeze Puts Promising South African HIV Vaccine Trials on Hold
The development of a promising HIV vaccine led by South African researchers has been halted due to funding cuts from USAID, following U.S. President Donald Trump's policy changes. The vaccine program,
US aid freeze could set back Africa’s fight against HIV by years, researchers warn
Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world in shock
Trump's foreign aid freeze halted a crucial program fighting HIV in Africa. Here's what's at stake
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world’s most successful responses to a disease
South African scientists were testing a promising HIV vaccine. Then came Trump’s aid cuts
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work.
This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
Healio3d
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
devdiscourse3d
Global Health Concerns: Bird Flu, HIV Trials, and Pharma Controversies
A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...
HUB21h
The basics of vaccines and vaccination
Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Rolling Out10d
How new strategies are changing the fight against HIV
Advancements in medicine and public health strategies continue to reshape the HIV landscape. The future of prevention lies in expanding access to innovative treatment options and developing new ...
RFK Jr’s appointment resurrects false claims about ‘depopulation’ via vaccines
Vaccine critic Robert F. Kennedy Jr. was confirmed as the new US health secretary on3, 2025. His nomination in mid-November led to a resurgence of claims that question the efficacy of vaccines. Posts ...
Science Daily3d
HIV and AIDS News
Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective ...
US aid freeze sows disruption in HIV, malaria product supply chains
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...